Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230927002
TCTR20230927002
Not yet recruiting
Not Applicable

Efficacy and safety of Thromboprophylaxis in Critically Ill Medical Patients: A Prospective, single centre study

Faculty of Medicine, Chiang Mai University0 sites462 target enrollmentSeptember 27, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsvenous thromboembolismDeep vein thrombosisPulmonary embolismcritical illnessvenous thromboembolismDeep vein thrombosisPulmonary embolismpharmacological thromboprophylaxismechanical thromboprophylaxis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
venous thromboembolismDeep vein thrombosisPulmonary embolismcritical illness
Sponsor
Faculty of Medicine, Chiang Mai University
Enrollment
462
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. age over 18 year old
  • •2\. following indication
  • •a.admit in critical care unit
  • •b.at least 1 condition below
  • •i.respiratory failure, need for mechanical ventilator
  • •ii.Acute kidney injury impending to renal replacement therapy
  • •iii.sepsis which SOFA score over 2 (reference from The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis\-3\)
  • •iv.hemodynamic unstable

Exclusion Criteria

  • •1\.taken anticoagulant during study
  • •2\.history of thrombophilia
  • •3\.undergone major operation 3 months prior to study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Thromboprophylaxis in patients with moderate COVID-19COVID-19
JPRN-UMIN000046519Port said University124
Recruiting
Phase 1
Study evaluating thromboprophylaxis in patients with advanced germ cell tumours of good or intermediate prognosisThromboprophylaxis in good and intermediate prognosis advanced germ cell tumorsMedDRA version: 20.0Level: LLTClassification code: 10075819Term: Testicular germ cell tumor Class: 10029104Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2022-502426-41-00Institut Gustave Roussy387
Completed
Not Applicable
Evaluation of the efficacy and safety of thromboprophylaxis regimens in patients after the Fontan procedurePatients after the Fontan procedure
JPRN-UMIN000044127Showa University1,903
Not yet recruiting
Not Applicable
Comparative outcomes of thromboprophylaxis between low molecular weight heparin (LMWH) and rivaroxaban in surgical gastrointestinal cancer patientsrivaroxaban &#44thromboprophylaxisthromboprophylaxis &#44surgical &#44cancer
TCTR20190712003Ramathibodi hospital760
Recruiting
Phase 4
Pre- vs. postoperative thromboprophylaxis for liver resection – a prospective, multicentre, randomized controlled trial (PREPOSTEROUS trial)
2024-519726-20-00Oslo University Hospital HF500